Home LiteratureArticle Details
PMID: 2962747 Published · ppublish English Journal Article Research Support, Non-U.S. Gov't Research Support, U.S. Gov't, P.H.S.

Generation of CD8 (T8) cytotoxic cells has a preferential requirement for CD4+2H4- inducer cells.

Cellular immunology ·Vol. 111 ·No. 2 ·1988-02-00 ·Pages 379-89

Kalish RS, Morimoto C, Schlossman SF

Abstract

CD8 (T8) cells are capable of both suppression and cytotoxicity. However, we have found that the activation of CD8 cytotoxic cells has a preferential requirement for a different CD4 (T4) subset from that previously reported for the activation of CD8 suppressor cells. We have recently characterized two monoclonal antibodies which subdivide CD4 cells into inducers of help for antibody production (CD4+ 4B4+) and inducers of CD8 mediated suppression (CD4+2H4+). We now report that CD4+4B4+2H4- cells also preferentially induce CD8-mediated cytotoxicity. Human peripheral blood T cells were fractionated into CD8, CD4, CD4+2H4+, and CD4+2H4- populations by both the adherence to antibody-coated plates and the fluorescence-activated cell sorter. The cells were cultured 6 days with irradiated allogeneic non-T cells and a cytotoxicity assay was then performed using cryopreserved non-T cells as targets. It was found that the combination of CD4+2H4- cells and CD8 cells resulted in greater cytotoxicity than either CD4 + CD8, or CD4+2H4+ + CD8. The combination of CD4+2H4+ cells with CD8 cells resulted in minimal cytotoxicity, which was similar to that generated by CD8 cells alone. These results were confirmed using anti-4B4 to positively select the reciprocal CD4 subset. Furthermore, the cytotoxicity induced by CD4+2H4- cells was alloantigen specific and Class I major histocompatibility complex restricted. As both CD4+2H4+ and CD4+2H4- cells proliferate equally well to alloantigen and produce similar levels of interleukin 2 (IL-2), it is likely that the generation of CD8 cytotoxic cells requires a signal in addition to IL-2.

MeSH Terms
Antibodies, Monoclonal Antigens, Differentiation, T-Lymphocyte/analysis Cytotoxicity, Immunologic HLA Antigens/immunology HLA-D Antigens/immunology Humans Immunity, Cellular Interleukin-2/biosynthesis T-Lymphocytes, Cytotoxic/immunology T-Lymphocytes, Regulatory/immunology
Chemicals
Antibodies, Monoclonal Antigens, Differentiation, T-Lymphocyte HLA Antigens HLA-D Antigens Interleukin-2
Authors & Affiliations
3 authors, click to expand affiliations / ORCID
Kalish R S
Department of Medicine, Harvard Medical School, Boston, Massachusetts 02115.
Morimoto C
Schlossman S F
Article Info
Journal
Cellular immunology
Abbr.
Cell Immunol
ISSN
0008-8749
Published
1988-02-00
Pages
379-89
Language
English
Region
Netherlands
NLM ID
1246405
Subset
IM
Grants
NIAID NIH HHS · AI 12069 · United States
NIADDK NIH HHS · AM 33713 · United States
NCI NIH HHS · CA 19589 · United States
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com